161 related articles for article (PubMed ID: 11159984)
1. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.
Satoskar AR; Bozza M; Rodriguez Sosa M; Lin G; David JR
Infect Immun; 2001 Feb; 69(2):906-11. PubMed ID: 11159984
[TBL] [Abstract][Full Text] [Related]
2. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.
Holowka T; Castilho TM; Garcia AB; Sun T; McMahon-Pratt D; Bucala R
FASEB J; 2016 Jun; 30(6):2249-65. PubMed ID: 26956417
[TBL] [Abstract][Full Text] [Related]
3. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
4. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium.
Xu D; McSorley SJ; Tetley L; Chatfield S; Dougan G; Chan WL; Satoskar A; David JR; Liew FY
J Immunol; 1998 Feb; 160(3):1285-9. PubMed ID: 9570545
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
[TBL] [Abstract][Full Text] [Related]
6. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
Okwor I; Jia P; Uzonna JE
J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
[TBL] [Abstract][Full Text] [Related]
9. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
[TBL] [Abstract][Full Text] [Related]
10. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection.
Monteforte GM; Takeda K; Rodriguez-Sosa M; Akira S; David JR; Satoskar AR
J Immunol; 2000 Jun; 164(11):5890-3. PubMed ID: 10820270
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps.
Rodríguez-Sosa M; Rosas LE; David JR; Bojalil R; Satoskar AR; Terrazas LI
Infect Immun; 2003 Mar; 71(3):1247-54. PubMed ID: 12595439
[TBL] [Abstract][Full Text] [Related]
12. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
13. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
Aguilar-Torrentera F; Carlier Y
Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium.
Koebernick H; Grode L; David JR; Rohde W; Rolph MS; Mittrücker HW; Kaufmann SH
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13681-6. PubMed ID: 12271144
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
Shankar AH; Morin P; Titus RG
Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
[TBL] [Abstract][Full Text] [Related]
17. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
18. Early IL-4 production does not predict susceptibility to Leishmania major.
Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
[TBL] [Abstract][Full Text] [Related]
19. Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway.
Rosas LE; Keiser T; Pyles R; Durbin J; Satoskar AR
Eur J Immunol; 2003 Jul; 33(7):1799-805. PubMed ID: 12811839
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
